Title	Publication Date	Language	Citations
Early Mucosal Healing With Infliximab Is Associated With Improved Long-term Clinical Outcomes in Ulcerative Colitis	2011/10/01	English	673
The natural history of fistulizing Crohn's disease in Olmsted County, Minnesota	2002/04/01	English	671
Trough Concentrations of Infliximab Guide Dosing for Patients With Inflammatory Bowel Disease	2015/06/01	English	667
Increased De Novo Lipogenesis Is a Distinct Characteristic of Individuals With Nonalcoholic Fatty Liver Disease	2014/03/01	English	665
Nonalcoholic Fatty Liver Disease 2020: The State of the Disease	2020/05/01	English	663
Comparison of scheduled and episodic treatment strategies of infliximab in Crohn’s disease	2004/02/01	English	660
Hepatocellular carcinoma: Recent trends in the United States	2004/11/01	English	659
Drug-Induced Liver Injury: An Analysis of 461 Incidences Submitted to the Spanish Registry Over a 10-Year Period	2005/08/01	English	657
Altered rectal perception is a biological marker of patients with irritable bowel syndrome	1995/07/01	English	654
Mitochondrial injury, oxidative stress, and antioxidant gene expression are induced by hepatitis C virus core protein	2002/02/01	English	650
Definition of Phenotypic Characteristics of Childhood-Onset Inflammatory Bowel Disease	2008/10/01	English	650
Combination Therapy With Infliximab and Azathioprine Is Superior to Monotherapy With Either Agent in Ulcerative Colitis	2014/02/01	English	649
Simplified assessment of segmental colonic transit	1987/01/01	English	646
Short-Chain Fatty Acids Activate GPR41 and GPR43 on Intestinal Epithelial Cells to Promote Inflammatory Responses in Mice	2013/08/01	English	645
Updated International Consensus Diagnostic Criteria for Eosinophilic Esophagitis: Proceedings of the AGREE Conference	2018/10/01	English	645
Interactions Between the Intestinal Microbiome and Liver Diseases	2014/05/01	English	644
Nonalcoholic fatty liver disease	2002/05/01	English	642
Aging of Hepatitis C Virus (HCV)-Infected Persons in the United States: A Multiple Cohort Model of HCV Prevalence and Disease Progression	2010/02/01	English	641
Bile Acid Is a Host Factor That Regulates the Composition of the Cecal Microbiota in Rats	2011/11/01	English	638
Burden of Gastrointestinal, Liver, and Pancreatic Diseases in the United States	2015/12/01	English	633
Liver Transplantation for Hepatocellular Carcinoma: A Model Including α-Fetoprotein Improves the Performance of Milan Criteria	2012/10/01	English	628
Surveillance Imaging and Alpha Fetoprotein for Early Detection of Hepatocellular Carcinoma in Patients With Cirrhosis: A Meta-analysis	2018/05/01	English	628
Long-term Therapy With Adefovir Dipivoxil for HBeAg-Negative Chronic Hepatitis B for up to 5 Years	2006/12/01	English	625
Etanercept for active Crohn's disease: A randomized, double-blind, placebo-controlled trial	2001/11/01	English	625
Findings From a Randomized Controlled Trial of Fecal Transplantation for Patients With Ulcerative Colitis	2015/07/01	English	623
A Randomized Controlled Trial of Radiofrequency Ablation With Ethanol Injection for Small Hepatocellular Carcinoma	2005/07/01	English	623
Ledipasvir and Sofosbuvir Plus Ribavirin for Treatment of HCV Infection in Patients With Advanced Liver Disease	2015/09/01	English	618
Predictors of Crohn’s Disease	2006/03/01	English	616
Subcutaneous Golimumab Induces Clinical Response and Remission in Patients With Moderate-to-Severe Ulcerative Colitis	2014/01/01	English	615
Prevalence of Barrett’s Esophagus in the General Population: An Endoscopic Study	2005/12/01	English	614